SEARCH

SEARCH BY CITATION

References

  • 1
    Davis CL. Impact of pretransplant renal failure: When is listing for kidney–liver indicated? Liver Transplant 2005; 11(Suppl 2): S35S44.
  • 2
    Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival inn patients undergoing orthotopic liver transplantation. Hepatology 2002; 35(5): 11791185.
  • 3
    Gonwa TA, Klintmalm GB, Levy M, Jennings LS, Goldstein RM, Husberg BS. Impact of pretransplant renal function on survival after liver transplantation. Transplantation 1995; 59(3): 361365.
  • 4
    Gonwa TA, McBride MA, Anderson K, Mai ML, Wadei H, Ahsan N. Continued influence of preoperative renal function on outcome of orthtopic liver transplant in the US: Where will MELD lead us? Am J Transplant 2006; 6(11): 26512659.
  • 5
    Ojo AO, Held PJ, Port FK et al. Chronic renal failure after transplantation of a nonrenal organ. New Engl J Med 2003; 349(10): 931940.
  • 6
    Campbell MS, Kotlyar DS, Brensinger CM et al. Renal function after orthotopic liver transplantation is predictted by duration of pretransplantation creatinine elevation. Liver Transplant 2005; 11(9): 10481055.
  • 7
    Ruiz R, Kunitake H, Wilkinson AH et al. Longterm analysis of combined liver–kidney transplantation at a single center. Arch Surg 2006; 141: 18.
  • 8
    Pichler R, Dittrich MO, Anderson AE et al. Prediction of benefit from simultaneous liver–kidney transplantation versus liver-alone transplantation: Potential role for native kidney biopsy. J Am Soc Nephrol 2006; 17: 795A.
  • 9
    Axelsen RA, Crawford DHG, Endre ZH et al. Renal glomerular lesions in unselected patients with cirrhosis undergoing orthotopic liver transplantation. Pathology 1995; 27(July): 237246.
  • 10
    McGuire BM, Julian BA, Bynon J et al. Glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation. Ann. Intern. Med 2006; 144(10): 735741.
  • 11
    Jouet P, Meyrier A, Mal F et al. Transjugular renal biopsy in the treatment of patients with cirrhosis and renal abnormalities. Hepatology 1996; 24(5): 11431147.
  • 12
    Sam R, Leehey DJ, Picken MM. Transjugular renal biopsy in patients with liver disease. Am J Kidney Dis 2001; 37: 13041307.
  • 13
    Coppo R, D'Amico G. Factors predicting progression of IgA nephropathies. J Nephrol 2005; 18(5): 503512.
  • 14
    Davis CL, Gonwa TA, Wilkinson AH. Identification of patients best suited for combined liver–kidney transplantation: Part II. Liver Transplant 2002; 8(3): 193211.
  • 15
    Fong TL, Bunnapradist S, Jordan SC, Selby RR, Cho YW. Analysis of the United Network for Organ Sharing database comparing renal allografts and patient survival in combined liver–kidney transplantation with the contralateral allografts in kidney alone or kidney–pancreas transplantation. Transplantation 2003; 76(2): 348353.
  • 16
    Simpson N, Cho YW, Cicciarelli MC, Selby RR, Fong TL. Comparison of renal allograft outcomes in combined liver–kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: Analysis of UNOS database. Transplanation 2006; 82(10): 12981303.
  • 17
    Ruiz R, Barri YM, Jennings LW et al. Hepatorenal syndrome: A proposal for kidney after liver transplantation (KALT). Liver Transplant 2007; in press.
  • 18
    Pham PTT, P.C.T. P, Rastogi A, Wilkinson AH. Review article: Current management of renal dysfunction in the cirrhotic patient. Aliment Pharmacol Ther 2005; 21: 949961.
  • 19
    Johnson RJ, Feehally J. Investigation of Renal Disease. In: JohnsonRJ, FeehallyJ, eds. Comprehensive clinical nephrolgoy. London : Mosby, 2003.
  • 20
    Guevara M, Rodes J. Hepatorenal syndrome. Int J Biochem Cell Biol 2005; 37(1): 2226.
  • 21
    Wong F. The use of TIPS in chronic liver disease. Ann Hepatol 2006; 5(1): 515.
  • 22
    Wong F, Pantea L, Sniderman K. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology 2004; 40(1): 5564.
  • 23
    Gonwa TA, Jennings LS, Mai ML, Stark PC, Levey AS, Klintmalm GB. Estimation of glomerular filtration rates before and after orthotopic liver transplantation: Evaluation of current equations. Liver Transplant 2004; 10(2): 301309.
  • 24
    Gonwa TA, Mai ML, Melton LB et al. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: Risk of development and treatment. Transplantation 2001; 72(12): 19341939.